2025 · 3rd Quarter (July 1 - Sep 30)

DAIICHI SANKYO INC

Filed by DAIICHI SANKYO, INC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2025
Income: Not reported
Expenses: $220,000.00
Registrant: DAIICHI SANKYO, INC.
Client: DAIICHI SANKYO INC
Filing UUID: 327a723c-94e2-499d-880a-b7f85a6e50bb
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Discussions regarding H.R.946, the ORPHAN Cures Act Discussions related to H.R.2319, the Women and Lung Cancer Research and Preventative Services Act Discussions related to the Protecting Patient Access to Cancer and Complex Therapies Act reintroduction

Literal federal measure citations: H.R.946, H.R.2319

TAX · Taxation/Internal Revenue Code

Discussions regarding tax reform and tariffs

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.